Rezultati pretraživanja
  1. prije 15 sati
  2. prije 12 sati
  3. 4. velj
  4. prije 7 sati

    How Do You Trust Your CRO to Manage Your Bioanalytical Drug Development? How to predict if a bioanalytical CRO has the capacity to support a company’s drug development needs? Learn how:

  5. prije 12 sati

    Check out my recent article in Pharmaceutical Technology on the potential impact of in 2020.

  6. prije 13 sati

    Outsourcing in the Cell & Gene Therapy Space - Steven Anderson PhD, CSO Covance, explains how specialized and coordinated capabilities aim to accelerate and reduce risk for sponsors.

  7. prije 14 sati

    BerGenBio Meets Efficacy Endpoint For First Stage Of Phase II Trial With AXL Inhibitor Bemcentinib in Combination With Keytruda in NSCLC Patients Progressing on Immune Checkpoint Inhibitors

  8. prije 16 sati

    "We are happy to expand our services on neurodegenerative diseases to cover Parkinson’s disease", thanks to our new partnership with OrganoTherapeutics. Learn more at

  9. prije 19 sati

    Our CSO, Gareth Jenkins, is attending ’s in Glasgow. Be sure to say hello to him at the event and find out about our use of transformational technology for more efficient . Get in touch to arrange a meeting here:

  10. prije 21 sat

    New development project? Find out how services can help you on your journey. Drop by Booth A68-A70 at

  11. 4. velj

    Tomorrow we will be set up at the 4th Drug Development Summit in London! If you at the summit, don’t miss your chance to listen to our Director of Microbiology Jeff Heiser at 10 am!

  12. 4. velj

    This World Cancer Day, we recognise that our commitment to act will lead to powerful progress in reducing the global impact of cancer. Together we can win the battle against

  13. 4. velj

    is beginning to transform the historically tortuous and expensive process of bringing a new drug to the clinic.

  14. 4. velj

    We're excited to join for the Biomarker Series Conference on our home turf of Manchester! Swing by Booth 1 to discuss how we can accelerate your , or ask us where our favourite bars are 🍸

  15. 4. velj

    With our in , we won't give up the fight for better patient outcomes and the future of a cancer-free world

  16. 3. velj

    Bristol-Myers withdraws Opdivo/Yervoy lung cancer EU application — but others are incoming – Endpoints News

  17. Meet , CEO of CILcare, at the LSX World Congress in London on February 4-5! She will give a presentation about CILcare tomorrow at 4:30 PM during the Biotech Inv€€$table Showcase.

  18. 3. velj

    Global Cancer Drug Market is expected to reach $176.509 million by 2025

  19. 31. sij

    Speaking solely as mom of a kid w/ , I’m grateful for the & thank all who joined & ran these . That said, a product that still requires allergen avoidance, 100% avail of epi, & can itself cause anaphylaxis is a 👎🏼 for me as a mom. 😞

    Prikaži ovu nit
  20. 31. sij

    From a fifth floor highrise in , MMS redefines the CRO experience via its strong, insightful team of global colleagues in HITEC CIty. Start a conversation:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.